T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.45B |
| 2 |
Pinterest
PINS
|
+$1.89B |
| 3 |
T-Mobile US
TMUS
|
+$1.89B |
| 4 |
Zoom
ZM
|
+$1.77B |
| 5 |
UiPath
PATH
|
+$1.71B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$3.66B |
| 2 |
Caterpillar
CAT
|
+$1.32B |
| 3 |
Netflix
NFLX
|
+$1.18B |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$1.15B |
| 5 |
Micron Technology
MU
|
+$1.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.62% |
| 2 | Healthcare | 16.07% |
| 3 | Consumer Discretionary | 15.29% |
| 4 | Communication Services | 13.46% |
| 5 | Financials | 12.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
AngioDynamics
ANGO
$647M
| $1.27M | ﹤0.01% |
46,906
+7,108
| +18% | +$174K |
|
|
CALY
1952
Callaway Golf Company
CALY
$2.95B
| $1.27M | ﹤0.01% |
37,694
+2,187
| +6% | +$70.3K |
|
1953
CALL
AstraZeneca
AZN
$244B
| $1.27M | ﹤0.01% |
+10,600
| New | +$1.16M |
|
|
B
1954
Barrick Mining
B
$67.3B
| $1.27M | ﹤0.01% |
61,230
-4,331,355
| -99% | -$97.6M |
|
1955
Sterling Infrastructure
STRL
$16.8B
| $1.27M | ﹤0.01% |
52,510
-3,500
| -6% | -$78.3K |
|
1956
V2X
VVX
$2.55B
| $1.26M | ﹤0.01% |
26,564
+2,224
| +9% | +$114K |
|
|
JNCE
1957
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $1.26M | ﹤0.01% |
185,858
+45,232
| +32% | +$376K |
|
|
ONEM
1958
DELISTED
1Life Healthcare
ONEM
| $1.26M | ﹤0.01% |
38,209
+5,937
| +18% | +$224K |
|
|
UCB
1959
United Community Banks
UCB
$4.43B
| $1.26M | ﹤0.01% |
39,424
+1,986
| +5% | +$66.9K |
|
|
DNB
1960
DELISTED
Dun & Bradstreet
DNB
| $1.26M | ﹤0.01% |
58,858
-11,542,664
| -99% | -$258M |
|
1961
International Bancshares
IBOC
$4.52B
| $1.26M | ﹤0.01% |
29,276
+984
| +3% | +$45.9K |
|
|
SYKE
1962
DELISTED
SYKES Enterprises Inc
SYKE
| $1.26M | ﹤0.01% |
23,415
+109
| +0.5% | +$4.85K |
|
1963
HF Sinclair
DINO
$15.6B
| $1.25M | ﹤0.01% |
38,152
-200,213
| -84% | -$6.96M |
|
|
MNR
1964
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $1.25M | ﹤0.01% |
66,611
+49
| +0.1% | +$920 |
|
|
AQUA
1965
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $1.25M | ﹤0.01% |
36,849
+3,082
| +9% | +$92.7K |
|
1966
Qiagen
QGEN
$8.93B
| $1.24M | ﹤0.01% |
24,245
+113
| +0.5% | +$5.84K |
|
|
TPIC
1967
DELISTED
TPI Composites
TPIC
| $1.24M | ﹤0.01% |
25,698
+1,031
| +4% | +$50.7K |
|
1968
Crinetics Pharmaceuticals
CRNX
$8.96B
| $1.24M | ﹤0.01% |
65,925
+17,060
| +35% | +$300K |
|
|
RWT
1969
Redwood Trust
RWT
$592M
| $1.24M | ﹤0.01% |
102,928
-46,708
| -31% | -$521K |
|
1970
Apogee Enterprises
APOG
$897M
| $1.24M | ﹤0.01% |
30,443
+382
| +1% | +$14.4K |
|
1971
TTM Technologies
TTMI
$14.5B
| $1.24M | ﹤0.01% |
86,533
-10,434
| -11% | -$156K |
|
|
AVTA
1972
DELISTED
Avantax, Inc. Common Stock
AVTA
| $1.24M | ﹤0.01% |
71,377
+2,335
| +3% | +$38.4K |
|
1973
Brookdale Senior Living
BKD
$3B
| $1.24M | ﹤0.01% |
156,277
-1,442
| -0.9% | -$10.4K |
|
1974
John Wiley & Sons Class A
WLY
$2.63B
| $1.24M | ﹤0.01% |
20,530
-2,180
| -10% | -$130K |
|
1975
DMC Global
BOOM
$155M
| $1.23M | ﹤0.01% |
21,927
-637
| -3% | -$35K |
|
Similar funds
T. Rowe Price Associates's Q2 2021 Portfolio in Review
As of Q2 2021, T. Rowe Price Associates held 3,000 positions worth $1.08T, up 8% from $999B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2021 filing shows 159 new, 1,164 increased, 1,499 reduced and 84 closed positions. Its largest new stake was UiPath: 23,377,090 shares worth $1.52B. The largest sale was Alibaba, an estimated $3.66B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2021 buy was UiPath: 23,377,090 shares worth $1.52B.
- T. Rowe Price Associates added most to Microsoft in Q2 2021, an estimated $3.45B increase.
- T. Rowe Price Associates's biggest Q2 2021 reduction was Alibaba, cutting an estimated $3.66B.
- T. Rowe Price Associates fully exited Pershing Square Tontine Holdings, Ltd. in Q2 2021, selling an estimated $145M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.08T portfolio in Q2 2021.
- T. Rowe Price Associates opened 159 new positions and closed 84 in Q2 2021.
- T. Rowe Price Associates's portfolio value rose 8% quarter-over-quarter to $1.08T.
Based on T. Rowe Price Associates's 13F filing for Q2 2021, filed 16 Aug 2021.